Key result
CGRP infusion increases coronary collateral blood flow by ~22% in preclinical models.
Why the study?
The effect of calcitonin gene-related peptide on blood flow through well-developed coronary collateral vessels was not previously examined.
Does CGRP infusion increase collateral blood flow in adult mongrel dogs with well-developed coronary collateral vessels?
Does CGRP infusion increase collateral blood flow in adult mongrel dogs with well-developed coronary collateral vessels?
CGRP causes vasodilation of well-developed epicardial coronary collateral vessels, leading to increased collateral blood flow in a canine model.
CGRP may dilate mature coronary collaterals and increase retrograde flow; leaves open any therapeutic role in human CAD.
This study was performed to examine the effect calcitonin gene-related peptide (CGRP) on blood flow through well-developed coronary collateral vessels. Studies were performed in 9 adult mongrel dogs 4-6 months after embolic occlusion of the left anterior descending coronary artery (LAD) with a hollow intravascular plug to stimulate collateral vessel growth. At the time of study, the LAD was cannulated to determine inter-arterial collateral flow from measurement of retrograde blood flow. Radioactive microspheres were injected during retrograde flow collection to determine continuing tissue flow in the collateral dependent region. CGRP was infused into the left main coronary artery in a dose of 0.2 microgram/kg/min to reach collateral vessels originating from the left coronary system. Retrograde blood flow was 40 +/- 9 ml/min during basal conditions and increased 22 +/- 9% in response to infusion of CGRP (n = 9, p < 0.05). Tissue flow to the collateral-dependent myocardial region did not change in response to CGRP infusion. Isolated rings of epicardial collateral vessels contracted with prostaglandin F2 alpha (PGF2 alpha) underwent relaxation in response to CGRP which was similar in magnitude to that of normal coronary arteries of comparable size. These data demonstrate that CGRP causes vasodilation of well-developed epicardial coronary collateral vessels, resulting in an increase in collateral blood flow.
No takes yet. Share an insight, caveat, or question.
Quebbeman et al. (1993) studied well-developed coronary collateral vessels (n=9). Calcitonin gene-related peptide (CGRP) vs. basal conditions was evaluated on retrograde blood flow (22 +/- 9% increase, p=< 0.05). Infusion of calcitonin gene-related peptide increased retrograde blood flow by 22 +/- 9% from basal conditions (40 +/- 9 ml/min) in dogs with well-developed coronary collaterals (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: